Merck in Talks to Acquire Cubist for ~$100/Share
December 05, 2014 at 23:24 PM EST
Merck & Co Inc. (NYSE: MRK), is reportedly in talks to acquire Lexington, MA-based Cubist Pharmaceuticals Inc. (NASDAQ: CBST) for around ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.